Market revenue in 2023 | USD 75.7 million |
Market revenue in 2030 | USD 126.3 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.36% in 2023. Horizon Databook has segmented the Brazil clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounts for 30.0% of the total trials conducted in Latin Ameica, owing to low cost, ease in patient recruitment, and presence of a diverse patient population. Changing regulation and logistics are primary challenges for biopharmaceutical companies and CROs, which is restraining entry of players into this market.
The regulatory approval process is stringent, as it involves approval from two entities Comissão Nacional de Ética em Pesquisa (CONEP) and Agência Nacional de Vigilância Sanitária (ANVISA). Recent regulatory changes in 2016 are expected to accelerate approval process, which may encourage biopharmaceutical and clinical trial supplies players to enter the market.
In 2015, Marken, a global supply chain solutions provider, established its largest depot in Brazil, which is expected to support growing number of clinical trials in Brazil. Increasing investments by market players in Brazil is a clear indication of growing opportunities, and the trend is expected to continue, thereby contributing to growth of clinical trial supply and logistics market.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account